258 related articles for article (PubMed ID: 28186998)
1. Somatic molecular subtyping of prostate tumors from HOXB13 G84E carriers.
Lotan TL; Torres A; Zhang M; Tosoian JJ; Guedes LB; Fedor H; Hicks J; Ewing CM; Isaacs SD; Johng D; De Marzo AM; Isaacs WB
Oncotarget; 2017 Apr; 8(14):22772-22782. PubMed ID: 28186998
[TBL] [Abstract][Full Text] [Related]
2. HOXB13 G84E-related familial prostate cancers: a clinical, histologic, and molecular survey.
Smith SC; Palanisamy N; Zuhlke KA; Johnson AM; Siddiqui J; Chinnaiyan AM; Kunju LP; Cooney KA; Tomlins SA
Am J Surg Pathol; 2014 May; 38(5):615-26. PubMed ID: 24722062
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of the HOXB13 G84E germline mutation in British men and correlation with prostate cancer risk, tumour characteristics and clinical outcomes.
Kote-Jarai Z; Mikropoulos C; Leongamornlert DA; Dadaev T; Tymrakiewicz M; Saunders EJ; Jones M; Jugurnauth-Little S; Govindasami K; Guy M; Hamdy FC; Donovan JL; Neal DE; Lane JA; Dearnaley D; Wilkinson RA; Sawyer EJ; Morgan A; Antoniou AC; Eeles RA;
Ann Oncol; 2015 Apr; 26(4):756-761. PubMed ID: 25595936
[TBL] [Abstract][Full Text] [Related]
4. A population-based assessment of germline HOXB13 G84E mutation and prostate cancer risk.
Karlsson R; Aly M; Clements M; Zheng L; Adolfsson J; Xu J; Grönberg H; Wiklund F
Eur Urol; 2014 Jan; 65(1):169-76. PubMed ID: 22841674
[TBL] [Abstract][Full Text] [Related]
5. G84E germline mutation in HOXB13 gene is associated with increased prostate cancer risk in Polish men.
Heise M; Jarzemski P; Bąk A; Junkiert-Czarnecka A; Pilarska-Deltow M; Haus O
Pol J Pathol; 2019; 70(2):127-133. PubMed ID: 31556563
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of the HOXB13 G84E prostate cancer risk allele in men treated with radical prostatectomy.
Beebe-Dimmer JL; Isaacs WB; Zuhlke KA; Yee C; Walsh PC; Isaacs SD; Johnson AM; Ewing CE; Humphreys EB; Chowdhury WH; Montie JE; Cooney KA
BJU Int; 2014 May; 113(5):830-5. PubMed ID: 24148311
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of the HOXB13 G84E mutation in Danish men undergoing radical prostatectomy and its correlations with prostate cancer risk and aggressiveness.
Storebjerg TM; Høyer S; Kirkegaard P; Bro F; ; Ørntoft TF; Borre M; Sørensen KD
BJU Int; 2016 Oct; 118(4):646-53. PubMed ID: 26779768
[TBL] [Abstract][Full Text] [Related]
8. Confirmation of the HOXB13 G84E germline mutation in familial prostate cancer.
Breyer JP; Avritt TG; McReynolds KM; Dupont WD; Smith JR
Cancer Epidemiol Biomarkers Prev; 2012 Aug; 21(8):1348-53. PubMed ID: 22714738
[TBL] [Abstract][Full Text] [Related]
9. HOXB13 G84E mutation in Finland: population-based analysis of prostate, breast, and colorectal cancer risk.
Laitinen VH; Wahlfors T; Saaristo L; Rantapero T; Pelttari LM; Kilpivaara O; Laasanen SL; Kallioniemi A; Nevanlinna H; Aaltonen L; Vessella RL; Auvinen A; Visakorpi T; Tammela TL; Schleutker J
Cancer Epidemiol Biomarkers Prev; 2013 Mar; 22(3):452-60. PubMed ID: 23292082
[TBL] [Abstract][Full Text] [Related]
10. Synergistic Interaction of
Sipeky C; Gao P; Zhang Q; Wang L; Ettala O; Talala KM; Tammela TLJ; Auvinen A; Wiklund F; Wei GH; Schleutker J
Clin Cancer Res; 2018 Dec; 24(24):6265-6276. PubMed ID: 30181389
[TBL] [Abstract][Full Text] [Related]
11. The HOXB13 G84E Mutation Is Associated with an Increased Risk for Prostate Cancer and Other Malignancies.
Beebe-Dimmer JL; Hathcock M; Yee C; Okoth LA; Ewing CM; Isaacs WB; Cooney KA; Thibodeau SN
Cancer Epidemiol Biomarkers Prev; 2015 Sep; 24(9):1366-72. PubMed ID: 26108461
[TBL] [Abstract][Full Text] [Related]
12. Recurrent HOXB13 mutations in the Dutch population do not associate with increased breast cancer risk.
Liu J; Prager-van der Smissen WJ; Schmidt MK; Collée JM; Cornelissen S; Lamping R; Nieuwlaat A; Foekens JA; Hooning MJ; Verhoef S; van den Ouweland AM; Hogervorst FB; Martens JW; Hollestelle A
Sci Rep; 2016 Jul; 6():30026. PubMed ID: 27424772
[TBL] [Abstract][Full Text] [Related]
13. Impact of the G84E variant on HOXB13 gene and protein expression in formalin-fixed, paraffin-embedded prostate tumours.
FitzGerald LM; Raspin K; Marthick JR; Field MA; Malley RC; Thomson RJ; Blackburn NB; Banks A; Charlesworth JC; Donovan S; Dickinson JL
Sci Rep; 2017 Dec; 7(1):17778. PubMed ID: 29259341
[TBL] [Abstract][Full Text] [Related]
14. Identification of Two Novel HOXB13 Germline Mutations in Portuguese Prostate Cancer Patients.
Maia S; Cardoso M; Pinto P; Pinheiro M; Santos C; Peixoto A; Bento MJ; Oliveira J; Henrique R; Jerónimo C; Teixeira MR
PLoS One; 2015; 10(7):e0132728. PubMed ID: 26176944
[TBL] [Abstract][Full Text] [Related]
15. HOXB13 mutation and prostate cancer: studies of siblings and aggressive disease.
Witte JS; Mefford J; Plummer SJ; Liu J; Cheng I; Klein EA; Rybicki BA; Casey G
Cancer Epidemiol Biomarkers Prev; 2013 Apr; 22(4):675-80. PubMed ID: 23396964
[TBL] [Abstract][Full Text] [Related]
16. Imputation of the rare HOXB13 G84E mutation and cancer risk in a large population-based cohort.
Hoffmann TJ; Sakoda LC; Shen L; Jorgenson E; Habel LA; Liu J; Kvale MN; Asgari MM; Banda Y; Corley D; Kushi LH; Quesenberry CP; Schaefer C; Van Den Eeden SK; Risch N; Witte JS
PLoS Genet; 2015 Jan; 11(1):e1004930. PubMed ID: 25629170
[TBL] [Abstract][Full Text] [Related]
17. Testing for the recurrent HOXB13 G84E germline mutation in men with clinical indications for prostate biopsy.
Schroeck FR; Zuhlke KA; Siddiqui J; Siddiqui R; Cooney KA; Wei JT
J Urol; 2013 Mar; 189(3):849-53. PubMed ID: 23036981
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of HOXB13 mutation in a population of Ashkenazi Jewish men treated for prostate cancer.
Alanee S; Shah S; Vijai J; Schrader K; Hamilton R; Rau-Murthy R; Sarrel K; Manschreck C; Eastham J; Offit K
Fam Cancer; 2013 Dec; 12(4):597-600. PubMed ID: 23475555
[TBL] [Abstract][Full Text] [Related]
19. HOXB13 interaction with MEIS1 modifies proliferation and gene expression in prostate cancer.
Johng D; Torga G; Ewing CM; Jin K; Norris JD; McDonnell DP; Isaacs WB
Prostate; 2019 Mar; 79(4):414-424. PubMed ID: 30560549
[TBL] [Abstract][Full Text] [Related]
20. The G84E mutation of HOXB13 is associated with increased risk for prostate cancer: results from the REDUCE trial.
Chen Z; Greenwood C; Isaacs WB; Foulkes WD; Sun J; Zheng SL; Condreay LD; Xu J
Carcinogenesis; 2013 Jun; 34(6):1260-4. PubMed ID: 23393222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]